Carlsmed
Company Snapshot
Carlsmed is a commercial-stage medical technology company focused on AI-enabled personalized spine surgery solutions. The company aims to improve outcomes and reduce healthcare costs for spine surgery by providing personalized surgical plans and custom interbody implants. Their key value proposition lies in the aprevo Technology Platform, which supports surgeons in achieving proper spinal alignment for patients with degenerative disc disease.
Key Financials
| Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | $27.2M | $13.8M | Not provided |
| YoY Growth | +97.1% | - | - |
| Adjusted Net Loss | -$24.3M | -$18.9M | Not provided |
| Margin % | -89.3% | -137.0% | - |
S-1 Highlights
Market & Competition
Carlsmed operates in the medical technology market, specifically focusing on spine surgery solutions. The company faces competition from other firms developing new technologies and products in the spinal surgery and implant market.
Use of Proceeds
The company plans to use the IPO proceeds to expand its commercial infrastructure and market access initiatives, including growing its direct sales team and independent sales agents.
Key Risk Factors
- ●The company faces the risk of technological advances by competitors rendering the aprevo Technology Platform non-competitive or obsolete.
- ●Carlsmed's growth strategy depends on maintaining and expanding its network of surgeons, which could be negatively impacted by external factors such as changes in reimbursement levels.
Reported Broker Availability
FidelityReported by users or publicly disclosed. Information is for reference only.